Shixian Deng1, Narine Bharat, Paloma de Prada
1Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, Columbia University, Box 84, 630 W168th Street, New York, NY 10032, USA. DWL1@columbia.edu.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Designing transition-state analogs using substrate-assisted catalysis effectively elicits catalytic antibodies. This novel strategy mimics high-energy transition states, improving antibody performance and reducing product inhibition in ester hydrolysis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: